Stephen J. Conner, MD D.D. Eisenhower Army Medical Center Family Medicine Residency Program, Ft. Gordon, Ga
Elaine Sullo, MLS East Carolina University, Greeneville, NC
Note: The opinions and assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the US Army or the US Department of Defense.
Practice guidelines published by the American Academy of Neurology recommend avoidance of prophylactic medications in pregnancy, if possible. They also recommend nonpharmacologic treatment as an acceptable option in pregnancy. If drug treatment is necessary, they recommend selecting an agent with the lowest risk of adverse effects to the fetus.3 Most review articles state that, if medication is necessary, it should be tailored towards other comorbidities, if possible; if there are no coexisting conditions, then calcium channel blockers or beta blockers would be the treatment of choice, based on safety data.1,10
